Position in PCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,906,832
+$212,903 QoQ
Shares Held
526,851
+16.6% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99.71528952208499.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2847104779150082.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. PCRX ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in PCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,906,832 | 526,851 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,693,929 | 451,852 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,004,255 | 232,994 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,553,523 | 106,842 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,940,848 | 118,344 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,160,608 | 114,682 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,045,373 | 69,460 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,175,018 | 76,023 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,206,602 | 109,740 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,211,637 | 35,911 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,974,333 | 96,947 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,738,905 | 143,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,031,840 | 25,284 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $1,342,774 | 17,594 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,060,271 | 67,480 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,153,168 | 109,878 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,222,897 | 366,231 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,192,311 | 88,348 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,976,952 | 83,171 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,826,397 | 146,813 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $1,330,302 | 39,675 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||